During the past decade, Azienda Ospedaliero Universitaria S.Maria della Misericordia - Gastroenterologia conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Azienda Ospedaliero Universitaria S.Maria della Misericordia - Gastroenterologia" are "Crohn's Disease" (2 trials), "Ulcerative Colitis" (2 trials) and "Complex Perianal Fistula" (1 trials). Many other conditions were trialed in "Azienda Ospedaliero Universitaria S.Maria della Misericordia - Gastroenterologia" in a lesser frequency.

Most popular intervention types in "Azienda Ospedaliero Universitaria S.Maria della Misericordia - Gastroenterologia" are "Drug" (3 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Cx601" (1 trials), "Darvadstrocel" (1 trials), "Mirikizumab" (1 trials) and "Mirikizumab IV" (1 trials). Other intervention names were less common.

The vast majority of trials in "Azienda Ospedaliero Universitaria S.Maria della Misericordia - Gastroenterologia" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Azienda Ospedaliero Universitaria S.Maria della Misericordia - Gastroenterologia". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Azienda Ospedaliero Universitaria S.Maria della Misericordia - Gastroenterologia, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Azienda Ospedaliero Universitaria S.Maria della Misericordia - Gastroenterologia, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".